Eubiotics Market Size 2026-2030
The eubiotics market size is valued to increase by USD 3.28 billion, at a CAGR of 8.4% from 2025 to 2030. Global regulations restricting prophylactic animal antibiotic usage will drive the eubiotics market.
Major Market Trends & Insights
- Europe dominated the market and accounted for a 44.1% growth during the forecast period.
- By Type - Poultry segment was valued at USD 2.57 billion in 2024
- By Product - Dry segment accounted for the largest market revenue share in 2024
Market Size & Forecast
- Market Opportunities: USD 5.13 billion
- Market Future Opportunities: USD 3.28 billion
- CAGR from 2025 to 2030 : 8.4%
Market Summary
- The Eubiotics Market fundamentally transforms modern animal nutrition by substituting conventional antimicrobial treatments with advanced microbial and organic health additives. Commercial feed manufacturers systematically adopt precision extraction methods to optimize intestinal microbiota behavior, directly responding to stringent mandates restricting sub-therapeutic antibiotic usage.
- This operational shift forces poultry integrators to reconfigure supply chains, emphasizing biological safety credentials and sustainable farming practices to meet retailer demands for clean-label protein. Consequently, facilities deploying encapsulated botanical extracts report a 20% reduction in mortality rates compared to traditional feeding regimens.
- Strict regulatory frameworks acting as primary drivers compel operators to transition toward these advanced feed formulations, enhancing systemic immunity. Conversely, the high thermal stress involved in intense pelleting operations challenges production stability, causing active microbial degradation if proper protective coating is not utilized.
- Effectively balancing these formulation costs against long-term performance gains remains critical for agricultural cooperatives aiming to maintain profitable feed conversion efficiency and structural flock integrity.
What will be the Size of the Eubiotics Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Get Free Sample
How is the Eubiotics Market Segmented?
The eubiotics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.
- Type
- Poultry
- Swine
- Ruminant
- Aquaculture
- Others
- Product
- Dry
- Liquid
- Product type
- Probiotics
- Prebiotics
- Organic acids
- Phytogenics
- Others
- Geography
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- North America
- US
- Canada
- Mexico
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- South America
- Brazil
- Argentina
- Chile
- Middle East and Africa
- Saudi Arabia
- South Africa
- Turkey
- UAE
- Israel
- Europe
By Type Insights
The poultry segment is estimated to witness significant growth during the forecast period.
The poultry segment dominates utilization as industrial facilities prioritize rapid growth alongside rigorous pathogen colonization suppression. Commercial operators increasingly rely on prophylactic antibiotic alternatives to ensure digestive efficiency optimization throughout the early developmental stages.
This shift transforms gut microflora balance from a voluntary measure into mandatory gut health infrastructure. Implementing microencapsulated organic acid matrices directly impacts flock viability, with integrated poultry producers observing a 15% improvement in nutrient utilization efficiency.
By guaranteeing intestinal epithelium nutrient absorption, operators actively reduce mortality and preserve structural health. This dynamic demonstrates how targeted synbiotics are indispensable for managing the compressed lifecycles of commercial flocks, enabling scalable efficiency across modern agricultural operations.
The Poultry segment was valued at USD 2.57 billion in 2024 and showed a gradual increase during the forecast period.
Regional Analysis
Europe is estimated to contribute 44.1% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Eubiotics Market Demand is Rising in Europe Get Free Sample
Geographic adoption patterns reveal distinct operational disparities driven by localized regulatory frameworks and diverse sustainable agricultural practices.
Europe enforces strict antimicrobial resistance mitigation policies, compelling agricultural cooperative standards to prioritize biological feed alternatives, which yields a 44% higher penetration of precision prebiotic extraction compared to emerging regions.
Conversely, North America accelerates the deployment of solid state fermentation bioreactors to optimize industrial broiler production, realizing a 22% improvement in manufacturing throughput.
European operators concentrate heavily on reducing livestock greenhouse gas emissions, whereas North American facilities prioritize scale and rapid livestock performance metrics.
Integrating advanced feed mill mixing equipment across European ruminant nutrition programs has lowered enteric disease incidence by 18%, while North American producers report a 15% reduction in processing costs. These regional strategies underscore how localized compliance dictates structural market evolution.
Market Dynamics
Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
- As commercial livestock production scales to meet rising protein demands, feed manufacturers focus heavily on replacing prophylactic antibiotic growth promoters with advanced microbial and organic solutions. This transition acts as a strict compliance necessity within modern supply chains.
- By strategically deploying prebiotics and encapsulated organic acids, feed compounders are successfully suppressing opportunistic bacterial pathogens before they can compromise flock or herd viability. This proactive health management approach directly impacts operational planning, as facilities utilizing these advanced additives experience a 30% greater consistency in animal weight gain compared to operations reliant on traditional regimens.
- Furthermore, the focus on enhancing intestinal tight junction integrity prevents pathogen translocation and reduces systemic inflammation, ensuring that metabolic energy is directed toward growth. By optimizing digestive function without resistance, commercial agricultural enterprises maintain long-term efficacy across continuous production cycles, mitigating the severe supply chain risks associated with antimicrobial-resistant outbreaks.
- Additionally, integrating specialized phytogenics plays a crucial role in improving cellular nutrient absorption, lowering total feed volume requirements and reducing overall procurement costs. Ultimately, these targeted biological interventions empower large-scale producers to align with stringent animal care standards while maintaining robust operational metrics.
What are the key market drivers leading to the rise in the adoption of Eubiotics Industry?
- Stringent global regulations restricting routine animal antibiotic usage compel commercial livestock producers to implement specialized biological additives.
- Strict international legislative mandates prohibiting sub-therapeutic antimicrobial usage act as the primary catalyst forcing livestock producers to restructure their nutritional regimens.
- This regulatory pressure compels the widespread adoption of precision nutrition integration to secure uninterrupted market access and avoid severe compliance penalties. Integrating encapsulated essential oil blends actively ensures competitive pathogen inhibition, providing a reliable defense against enteric diseases.
- Consequently, commercial swine operators deploying these interventions across swine production systems experience a 25% decrease in herd mortality, stabilizing supply chain predictability.
- The strategic utilization of beneficial yeast cultures significantly bolsters systemic immune resilience, reducing the reliance on reactive medical treatments by up to 18%.
- Implementing these advanced solutions secures robust feed conversion ratios, empowering enterprises to successfully scale antibiotic free supply chains while maintaining operational profitability.
What are the market trends shaping the Eubiotics Industry?
- The commercialization of postbiotic compounds and precision microbial solutions represents a defining trend in modern animal nutrition.
- The rapid integration of functional metabolomics and precision microbial profiling represents a dominant trend reshaping commercial animal nutrition strategies. This technological evolution occurs because feed compounder operations require heat stable postbiotic compounds to survive high temperature pelleting processes without losing biological efficacy. Consequently, facilities utilizing these resilient spore forming bacterial strains achieve a 20% improvement in survivability among early-stage livestock.
- Precision fermentation technologies actively facilitate optimal gastrointestinal microbiota modulation, allowing producers to satisfy rigorous animal welfare compliance standards while sustaining peak output. By reinforcing intestinal tight junction integrity, these innovations drastically lower veterinary intervention frequencies, directly preserving critical profit margins. Furthermore, implementing automated liquid delivery dosing ensures targeted application, lowering nutrient waste by 12% across integrated production networks.
What challenges does the Eubiotics Industry face during its growth?
- High initial formulation costs and feed integration complexities present significant operational challenges for manufacturers deploying advanced microbial technologies.
- Deploying multi strain probiotic encapsulation systems introduces severe formulation complexities and elevated procurement costs for commercial feed manufacturers. This structural challenge arises because live microorganisms demand superior thermal degradation resistance to survive the intense mechanical shear forces inherent in processing commercial feed formulations.
- Consequently, facilities lacking specialized cold-processing equipment experience a 30% loss in active microbial viability before reaching the animal. The chemical interference between volatile phytogenics and sensitive microflora further complicates matrix compatibility, leading to inconsistent efficacy in complex applications like aquaculture enterprise feeding. Overcoming these technical barriers demands extensive raw material consistency evaluation, which increases laboratory testing overhead by nearly 15%.
- Sustaining mucosal barrier reinforcement under unstable conditions continuously strains operational margins, severely complicating the maintenance of stringent biosecurity protocols and essential biological safety certifications.
Exclusive Technavio Analysis on Customer Landscape
The eubiotics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the eubiotics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Eubiotics Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, eubiotics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
ADDCON GmbH - Offers specialized organic acids, acidifier blends, and feed hygiene formulations to optimize livestock and aquaculture digestive health, enabling resilient agricultural production without routine antibiotics.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- ADDCON GmbH
- Adisseo France SAS
- Anpario plc
- Archer Daniels Midland Co.
- BASF SE
- BENEO GmbH
- Biorigin S.A.
- Cargill Inc.
- Dr. Eckel Animal Nutrition
- DSM Firmenich AG
- Evonik Industries AG
- Huvepharma Inc.
- Innov Ad NV SA
- International Flavors Inc.
- Kemin Industries Inc.
- Lallemand Inc.
- Lesaffre Group
- Novonesis Group
- Novus International Inc.
- Nutreco N.V.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Eubiotics market
- In the Packaged Foods and Meats industry, the implementation of stringent antimicrobial resistance mitigation policies has restricted standard prophylactic treatments, directly impacting Eubiotics demand by forcing livestock producers to adopt specialized biological additives to maintain regulatory compliance.
- The rapid expansion of certified antibiotic-free supply chains driven by retail consumer preferences has necessitated the integration of advanced fermentation systems into feed manufacturing, resulting in a 25% increase in the utilization of heat-resistant microbial compounds.
- Supply chain disruptions in traditional vitamin sourcing have accelerated the adoption of specialized metabolic profiling and beneficial fungal cultures within premix manufacturing facilities, improving feed efficiency by up to 12% while ensuring ingredient consistency.
- Environmental directives aimed at reducing livestock greenhouse gas emissions have catalyzed the deployment of precision feeding strategies, shifting procurement toward encapsulated acid formulations that enhance intestinal cellular integrity and lower overall nutrient excretion by nearly 18%.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Eubiotics Market insights. See full methodology.
| Market Scope | |
|---|---|
| Page number | 300 |
| Base year | 2025 |
| Historic period | 2020-2024 |
| Forecast period | 2026-2030 |
| Growth momentum & CAGR | Accelerate at a CAGR of 8.4% |
| Market growth 2026-2030 | USD 3276.2 million |
| Market structure | Fragmented |
| YoY growth 2025-2026(%) | 7.9% |
| Key countries | Germany, UK, France, Italy, Spain, The Netherlands, US, Canada, Mexico, China, India, Japan, South Korea, Australia, Indonesia, Brazil, Argentina, Chile, Saudi Arabia, South Africa, Turkey, UAE and Israel |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- Boardroom strategies across the agricultural sector now prioritize the integration of advanced fermentation systems to fundamentally overhaul livestock nutrition programs. The transition toward heat-resistant microbial components enables feed manufacturers to maintain active ingredient viability during aggressive thermal processing, directly resolving critical stability bottlenecks.
- Executive leadership teams mandate the adoption of encapsulated acid matrices to ensure strict alignment with international antimicrobial regulations, effectively mitigating compliance risks while sustaining production yields. Facilities integrating these advanced microbial inoculants report a 25% reduction in enteric disease outbreaks, streamlining veterinary interventions and stabilizing operational budgets.
- Spore-based bacterial additives provide essential durability in commercial transport, ensuring consistent efficacy upon delivery to the digestive tract. By achieving competitive pathogen exclusion, integrated poultry and swine operators systematically safeguard animal health without relying on restricted therapeutic chemicals. Implementing targeted metabolic profiling further refines dietary precision, allowing producers to customize nutritional inputs for specific growth phases.
- This targeted biological approach guarantees mucosal barrier strengthening, converting proactive nutritional investments into measurable operational resilience across modern supply chains.
What are the Key Data Covered in this Eubiotics Market Research and Growth Report?
-
What is the expected growth of the Eubiotics Market between 2026 and 2030?
-
USD 3.28 billion, at a CAGR of 8.4%
-
-
What segmentation does the market report cover?
-
The report is segmented by Type (Poultry, Swine, Ruminant, Aquaculture, and Others), Product (Dry, and Liquid), Product Type (Probiotics, Prebiotics, Organic acids, Phytogenics, and Others) and Geography (Europe, North America, APAC, South America, Middle East and Africa)
-
-
Which regions are analyzed in the report?
-
Europe, North America, APAC, South America and Middle East and Africa
-
-
What are the key growth drivers and market challenges?
-
Global regulations restricting prophylactic animal antibiotic usage, High initial formulation costs and feed integration strain
-
-
Who are the major players in the Eubiotics Market?
-
ADDCON GmbH, Adisseo France SAS, Anpario plc, Archer Daniels Midland Co., BASF SE, BENEO GmbH, Biorigin S.A., Cargill Inc., Dr. Eckel Animal Nutrition, DSM Firmenich AG, Evonik Industries AG, Huvepharma Inc., Innov Ad NV SA, International Flavors Inc., Kemin Industries Inc., Lallemand Inc., Lesaffre Group, Novonesis Group, Novus International Inc. and Nutreco N.V.
-
Market Research Insights
- The Eubiotics Market continually adapts to evolving animal care standards by integrating advanced intestinal support into bulk feed production. Processing operations increasingly transition toward precision dietary integration, moving away from prophylactic antimicrobials to optimize overall livestock growth metrics. Integrating automated fluid delivery systems has improved formulation accuracy by 25%, directly reducing raw material waste and operational overhead.
- Additionally, the strategic implementation of pathogen control protocols using tailored organic acids has demonstrated a 15% improvement in nutrient absorption rates, securing better ROI for large-scale swine producers. These targeted biological interventions ensure robust systemic health, empowering integrated producers to scale clean-label supply chains while simultaneously lowering veterinary intervention costs by up to 18%.
We can help! Our analysts can customize this eubiotics market research report to meet your requirements.
RIA - 
